<DOC>
	<DOCNO>NCT00733902</DOCNO>
	<brief_summary>Test efficacy safety 3 dos Osteoarthritis knee patient .</brief_summary>
	<brief_title>Tanezumab Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Osteoarthritis knee accord ACR criterion KellgrenLawrence xray grade 2 . Unwilling unable take nonopiate pain medication , nonopiate pain medication provide adequate pain relief candidate knee injection arthroplasty replace surgery . Pain level function level require protocol Screening Baseline . Willing discontinue pain medication ( acetaminophen permit certain level ) study . Must agree contraceptive requirement protocol applicable . Must agree treatment plan , schedule visit , procedure protocol . Pregnancy intent become pregnant study BMI great 39 severe pain , significant cardiac , neurological psychological condition , protocol limit laboratory blood pressure result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>monoclonal antibody</keyword>
	<keyword>RN624</keyword>
	<keyword>PF-04383119</keyword>
	<keyword>nerve growth factor</keyword>
	<keyword>anti-nerve growth factor</keyword>
	<keyword>OA</keyword>
	<keyword>pain</keyword>
</DOC>